ST Elevations in the Era of COVID-19

Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sang, Charlie Joseph, Heindl, Brittain, Von Mering, Gregory, Brott, Brigitta, Kopf, Robert S., Rajapreyar, Indranee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443235/
https://www.ncbi.nlm.nih.gov/pubmed/32855827
http://dx.doi.org/10.1155/2020/8845627
_version_ 1783573593537380352
author Sang, Charlie Joseph
Heindl, Brittain
Von Mering, Gregory
Brott, Brigitta
Kopf, Robert S.
Rajapreyar, Indranee
author_facet Sang, Charlie Joseph
Heindl, Brittain
Von Mering, Gregory
Brott, Brigitta
Kopf, Robert S.
Rajapreyar, Indranee
author_sort Sang, Charlie Joseph
collection PubMed
description Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician.
format Online
Article
Text
id pubmed-7443235
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74432352020-08-26 ST Elevations in the Era of COVID-19 Sang, Charlie Joseph Heindl, Brittain Von Mering, Gregory Brott, Brigitta Kopf, Robert S. Rajapreyar, Indranee Case Rep Cardiol Case Report Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician. Hindawi 2020-08-06 /pmc/articles/PMC7443235/ /pubmed/32855827 http://dx.doi.org/10.1155/2020/8845627 Text en Copyright © 2020 Charlie Joseph Sang III et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sang, Charlie Joseph
Heindl, Brittain
Von Mering, Gregory
Brott, Brigitta
Kopf, Robert S.
Rajapreyar, Indranee
ST Elevations in the Era of COVID-19
title ST Elevations in the Era of COVID-19
title_full ST Elevations in the Era of COVID-19
title_fullStr ST Elevations in the Era of COVID-19
title_full_unstemmed ST Elevations in the Era of COVID-19
title_short ST Elevations in the Era of COVID-19
title_sort st elevations in the era of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443235/
https://www.ncbi.nlm.nih.gov/pubmed/32855827
http://dx.doi.org/10.1155/2020/8845627
work_keys_str_mv AT sangcharliejoseph stelevationsintheeraofcovid19
AT heindlbrittain stelevationsintheeraofcovid19
AT vonmeringgregory stelevationsintheeraofcovid19
AT brottbrigitta stelevationsintheeraofcovid19
AT kopfroberts stelevationsintheeraofcovid19
AT rajapreyarindranee stelevationsintheeraofcovid19

Ejemplares similares